Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
142M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
46.9M
-
Shares change
-
+3.57K
-
Total reported value, excl. options
-
$452M
-
Value change
-
-$3.42M
-
Number of buys
-
33
-
Number of sells
-
-39
-
Price
-
$9.64
Significant Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) as of Q1 2022
96 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2022.
Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.9M shares
of 142M outstanding shares and own 33.1% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (8.93M shares), MPM ASSET MANAGEMENT LLC (4.95M shares), Deep Track Capital, LP (3.5M shares), CITADEL ADVISORS LLC (2.96M shares), Vida Ventures Advisors, LLC (2.96M shares), RA CAPITAL MANAGEMENT, L.P. (2.81M shares), Logos Global Management LP (2.73M shares), BlackRock Inc. (2.36M shares), Point72 Asset Management, L.P. (1.89M shares), and VANGUARD GROUP INC (1.39M shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.